|
|
 |
HERmark Breast Cancer Assay | | | General Information | |
| Vendor | | Monogram Biosciences | | Item | | HERmark Breast Cancer Assay | | Features | |
- A direct measure of HER2 total protein and functional homodimers compared to an indirect measure via gene amplification (FISH).
- Seven to ten times more sensitive than HER2 IHC testing.
- Dual antibody format provides greater specificity than secondary antibody approaches (IHC).
- Quantifies HER2 total protein receptors and functional HER2 homodimers over a broad continuum. (Shows HOW positive or HOW negative)
- The assay provides a robust, accurate, sensitive, and reproducible assessment of HER2 status using FFPE tissue specimens.
- HERmark is a CLIA-validated assay processed at Monogram Biosciences a CAP-certified central laboratory.
- Simple easy to read report typically in seven days.
| | Sensitivity | | Detects HER2 levels from 2,500 to over 1 million receptors per cell (7 - 10x more sensitive than IHC) | | Pricing |  | Inquire |
| | Product Description | |
| HERmark Breast Cancer Assay avoids errors and challenges associated with semi-quantitative protein-based assays, gene amplification approaches and lab-to-lab variability | |
| Monogram Biosciences | | Customer Service: (650) 635-1100 | | Web site: http://www.monogrambio.com/default.aspx | | Please mention Medcompare.com when you contact the vendor. |
| NOTE: Medcompare disclaims any information on this site. The information found on Medcompare (Drug Guide, Product Listings and otherwise) is intended for use by medical professionals. This information is not intended to replace the information, advice or instructions from a medical doctor. Pricing information is approximate, actual prices may vary. |
|
|
